These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7495702)

  • 1. Pharmacokinetics of tamoxifen in premenopausal and postmenopausal women with breast cancer.
    Lien EA; Anker G; Ueland PM
    J Steroid Biochem Mol Biol; 1995 Nov; 55(2):229-31. PubMed ID: 7495702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF; Lin HH; Torng PL; Huang SC
    Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment.
    Lien EA; Søiland H; Lundgren S; Aas T; Steen VM; Mellgren G; Gjerde J
    Breast Cancer Res Treat; 2013 Sep; 141(2):243-8. PubMed ID: 23996142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serum estradiol concentration is the main determinant of the estradiol concentration in normal breast tissue.
    Depypere HT; Bolca S; Bracke M; Delanghe J; Comhaire F; Blondeel P
    Maturitas; 2015 May; 81(1):42-5. PubMed ID: 25721699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.
    Wright JD; Desai VB; Chen L; Burke WM; Tergas AI; Hou JY; Accordino M; Ananth CV; Neugut AI; Hershman DL
    Am J Obstet Gynecol; 2017 Jul; 217(1):59.e1-59.e12. PubMed ID: 28341383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fracture incidence in pre- and postmenopausal women after completion of adjuvant hormonal therapy for breast cancer.
    Koopal C; Janssen-Heijnen ML; van de Wouw AJ; van den Bergh JP
    Breast; 2015 Apr; 24(2):153-8. PubMed ID: 25618224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging may be associated with concentrations of tamoxifen and its metabolites in breast cancer patients.
    Sheth HR; Lord G; Tkaczuk K; Danton M; Lewis LM; Langenberg P; Lim CK; Flaws JA
    J Womens Health (Larchmt); 2003 Oct; 12(8):799-808. PubMed ID: 14588130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.
    Saladores P; Mürdter T; Eccles D; Chowbay B; Zgheib NK; Winter S; Ganchev B; Eccles B; Gerty S; Tfayli A; Lim JS; Yap YS; Ng RC; Wong NS; Dent R; Habbal MZ; Schaeffeler E; Eichelbaum M; Schroth W; Schwab M; Brauch H
    Pharmacogenomics J; 2015 Feb; 15(1):84-94. PubMed ID: 25091503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer.
    Gjerde J; Geisler J; Lundgren S; Ekse D; Varhaug JE; Mellgren G; Steen VM; Lien EA
    BMC Cancer; 2010 Jun; 10():313. PubMed ID: 20565970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible deleterious effect of tamoxifen in premenopausal women with locoregional recurrence of breast cancer.
    Borner MM; Bacchi M; Castiglione M
    Eur J Cancer; 1996 Nov; 32A(12):2173-6. PubMed ID: 9014762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer.
    Hutson PR; Love RR; Havighurst TC; Rogers E; Cleary JF
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8722-7. PubMed ID: 16361559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid function in postmenopausal women with breast cancer on tamoxifen.
    Kostoglou-Athanassiou I; Ntalles K; Markopoulos C; Athanassiou P; Gogas J; Proukakis C
    Eur J Gynaecol Oncol; 1998; 19(2):150-4. PubMed ID: 9611055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing endocrine therapy for premenopausal and postmenopausal women with breast cancer.
    Cianfrocca M; Wolff AC
    Oncology (Williston Park); 2007 Jan; 21(1):63-9; discussion 69, 72, 75 passim. PubMed ID: 17313157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pronounced Interindividual But Not Intraindividual Variation in Tamoxifen and Metabolite Levels in Plasma During Adjuvant Treatment of Women With Early Breast Cancer.
    Fotoohi AK; Karim H; Lafolie P; Pohanka A; Östervall J; Hatschek T; Vitols S
    Ther Drug Monit; 2016 Apr; 38(2):239-45. PubMed ID: 26485084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer.
    Shushan A; Peretz T; Uziely B; Lewin A; Mor-Yosef S
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):141-4. PubMed ID: 8571997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
    Ilanchezhian S; Thangaraju M; Sachdanandam P
    Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toremifene in postmenopausal breast cancer. Efficacy, safety and cost.
    Mäenpää JU; Ala-Fossi SL
    Drugs Aging; 1997 Oct; 11(4):261-70. PubMed ID: 9342556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer.
    Morales M; Santana N; Soria A; Mosquera A; Ordovás J; Nóvoa J; Betancor P; Valerón PF; Díaz-Chico B; Chirino R
    Breast Cancer Res Treat; 1996; 40(3):265-70. PubMed ID: 8883969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patients.
    Lim JS; Sutiman N; Muerdter TE; Singh O; Cheung YB; Ng RC; Yap YS; Wong NS; Ang PC; Dent R; Schroth W; Schwab M; Chowbay B
    Br J Clin Pharmacol; 2016 Jun; 81(6):1142-52. PubMed ID: 26799162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.